Singapore markets open in 4 hours 44 minutes

Regen BioPharma, Inc. (RGBP)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.5700-0.0051 (-0.89%)
At close: 03:44PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Cash flows from operating activities
Net income
-839.786
1,024
2,227
-6,765
2,732
Stock-based compensation
-
348.372
0
0.001
-
Change in working capital
-50.009
-1,929
-3,137
6,300
-4,009
Accounts receivable
39.399
254.272
-41.082
-109.999
-34.1
Accounts payable
-4.249
0.875
-62.705
-18.988
18.487
Other working capital
-482.07
-173.917
-606.921
-1,131
18.645
Other non-cash items
258.42
249.715
116.568
-1,823
613.122
Net cash provided by operating activities
-482.07
-173.917
-606.921
-1,131
18.645
Cash flows from investing activities
Sales/maturities of investments
-
-
25
495
0
Net cash used for investing activities
-
-
25
495
0
Cash flows from financing activities
Debt repayment
-
-
-94.535
-
-26.5
Common stock issued
-
-
-
-
0
Net cash used provided by (used for) financing activities
472.484
243.75
-94.036
1,363
-26.5
Net change in cash
-10.039
69.833
-675.957
727.162
-7.855
Cash at beginning of period
87.7
51.204
727.162
0
7.855
Cash at end of period
78.114
121.037
51.204
727.162
0
Free cash flow
Operating cash flow
-482.07
-173.917
-606.921
-1,131
18.645
Free cash flow
-482.07
-173.917
-606.921
-1,131
18.645